1-5 of 5
Atsushi Kitabayashi
Close
Sort by
Journal Articles

Multicenter Phase II Clinical Trial of Nilotinib for Patients with Imatinib-Resistant or Intolerant CML From the East Japan CML Study Group (EJCML) Trial: Evaluation of Molecular Responses by the BCR-ABL1 Mutational Status and Plasma Trough Concentration of Nilotinib

Naoto Takahashi, MD, PhD, Masatomo Miura, PhD, Jun Kuroki, MD, PhD, Kinuko Mitani, MD, PhD, Atsushi Kitabayashi, MD, PhD, Osamu Sasaki, MD, PhD, Hideo Kimura, MD, PhD, Kiyotoshi Imai, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hideyoshi Noji, MD, PhD, Takeshi Kondo, MD, PhD, Akihisa Kuwayama, MD, PhD, Mutsuhito Motegi, MD, PhD, Yuichi Kato, MD, PhD, Kaoru Takahashi, MD, PhD, Masayuki Mita, MD, PhD, Hajime Saito, MD, PhD, Chikashi Yoshida, MD, PhD, Yoshihiro Torimoto, MD, PhD, Tomofumi Kimura, MD, PhD, Yuji Wano, MD, PhD, Jun Nomura, MD, PhD, Satoshi Yamamoto, MD, PhD, Ko Mayama, MD, PhD, Riko Honma, MD, PhD, Tomohiro Sugawara, MD, PhD, Shinji Sato, MD, PhD, Atsushi Shinagawa, MD, PhD, Akihiko Chubachi, MD, PhD, Hideo Harigae, MD, PhD, Kenichi Sawada, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1360.
https://doi.org/10.1182/blood.V120.21.1360.1360
Published: 2012
Journal Articles

Bortezomib Is Effective for Down Regulation of Gene Transcriptions Specifically Expressed in Clonogenic Myeloma Side Population Cells

Miho Nara, MD, Hiroyuki Tagawa, MD, PhD, Kazuaki Teshima, MD, Atsushi Watanabe, MD, PhD, Mitsugu Ito, MD, Atsushi Kitabayashi, MD, PhD, Masaaki Kume, MD, PhD, Yoshiaki Hatano, MD, PhD, Shinsuke Iida, MD, PhD, Kenichi Sawada, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3939.
https://doi.org/10.1182/blood.V120.21.3939.3939
Published: 2012
Journal Articles

Possibility of Lenalidomide Therapy and Determination of Its Ideal Dose for Patients with Relapsed or Refractory Multiple Myeloma

Seiji Shida, MD, Naoto Takahashi, MD, PhD, FJSIM, Masatomo Miura, PhD, Takenori Niioka, PhD, Morio Matsumoto, MD, Masao Hagihara, MD, Mutsuhito Motegi, MD, PhD, Masaaki Kume, MD, PhD, Jun Kuroki, MD, PhD, Atsushi Kitabayashi, MD, PhD, Yoshiaki Hatano, MD, PhD, Atsushi Watanabe, MD, PhD, Naohito Fujishima, MD, PhD, Yoshihiro Kameoka, MD, PhD, Hiroyuki Tagawa, MD, PhD, Makoto Hirokawa, MD, PhD, Kenichi Sawada, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4921.
https://doi.org/10.1182/blood.V120.21.4921.4921
Published: 2012
Journal Articles

Oligoclonal Expansion of Vδ1+ γδT Cells in Cyclosporine-Responsive Acquired Pure Red Cell Aplasia.

Makoto Hirokawa, MD, Naohito Fujishima, MD, Yuhta Oyama, MD, Masumi Fujishima, MD, Takahiro Horiuchi, MD, Atsushi Kitabayashi, MD, Ikuo Miura, MD, Ken-ichi Sawada, MD
Journal: Blood
Blood (2004) 104 (11): 3845.
https://doi.org/10.1182/blood.V104.11.3845.3845
Published: 2004
Journal Articles

Defective Apoptotic Signal Transduction Pathway Downstream of Caspase-3 in Human B-Lymphoma Cells: A Novel Mechanism of Nuclear Apoptosis Resistance

Yoshinari Kawabata, Makoto Hirokawa, Atsushi Kitabayashi, Takahiro Horiuchi, Jun Kuroki, Akira B. Miura
Journal: Blood
Blood (1999) 94 (10): 3523–3530.
https://doi.org/10.1182/blood.V94.10.3523.422k07_3523_3530
Published: 1999